Susquehanna International Group
TBIO

Susquehanna International Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Susquehanna International Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-87,300
Closed -$2.4M – 14046
2021
Q2 		$2.4M Sell
87,300
-66,600
-43% -$1.31M ﹤0.01% 5497
2021
Q1 		$2.54M Buy
153,900
+119,900
+353% +$2.73M ﹤0.01% 5344
2020
Q4 		$627K Sell
34,000
-69,300
-67% -$1.24M ﹤0.01% 7792
2020
Q3 		$1.41M Buy
103,300
+63,200
+158% +$974K ﹤0.01% 5310
2020
Q2 		$719K Buy
+40,100
New +$605K ﹤0.01% 6602

Susquehanna International Group's TBIO Position: Q3 2021 in Review

Susquehanna International Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 133,811 shares — an estimated $3.69M sold.

Susquehanna International Group first reported a position in TBIO in Q2 2019 and held it in 8 quarters. The position peaked at $3.69M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Susquehanna International Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Susquehanna International Group sold 133,811 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $3.69M.
  • Susquehanna International Group first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Susquehanna International Group's Translate Bio, Inc. Common Stock position peaked at $3.69M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.